References
- Van den Anker JN, Schwab M, Kearns GL. Developmental pharmacokinetics. Handb. Exp. Pharmacol.205, 51–75 (2011).
- Allegaert K, Verbesselt R, Naulaers G et al. Developmental pharmacology: neonates are not just small adults. Acta Clin. Belg.63(1), 16–24 (2008).
- Leeder JS, Kearns GL, Spielberg SP, van den Anker J. Understanding the relative roles of pharmacogenetics and ontogeny in pediatric drug development and regulatory science. J. Clin. Pharmacol.50(12), 1377–1387 (2010).
- Jacqz-Aigrain E. Drug policy in Europe research and funding in neonates: current challenges, future perspectives, new opportunities. Early Hum. Dev.87(Suppl. 1), S27–S30 (2011).
- George I, Mekahli D, Rayyan M, Levtchenko E, Allegaert K. Postnatal trends in creatinemia and its covariates in extremely low birth weight (ELBW) neonates. Pediatr. Nephrol.26(10), 1843–1849 (2011).
- Jacobs S, Hunt R, Tarnow-Mordi W, Inder T, Davis P. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst. Rev.17(4), CD003311 (2007).
- van den Berg H, van den Anker JN, Beijnen JH. Cytostatic drugs in infants: a review on pharmacokinetic data in infants. Cancer Treat. Rev. doi:10.1016/j.ctrv.2011.03.005 (2011) (Epub ahead of print).
- van den Anker JN, Allegaert K. Individualized dosing of aminoglycosides in neonates: mission accomplished or work in progress? Eur. J. Clin. Pharmacol.65(11), 1159–1160 (2009).
- De Cock RF, Piana C, Krekels EH, Danhof M, Allegaert K, Knibbe CA. The role of population PK-PD modelling in paediatric clinical research. Eur. J. Clin. Pharmacol.67(Suppl. 1), 5–16 (2011).
- Kearns GL. Beyond biomarkers: an opportunity to address the ‘pharmacodynamic gap’ in pediatric drug development. Biomark. Med.4(6), 783–786 (2010).
- Mussap M, Fanos V. Neonatal nephrology and laboratory medicine: an effective interdisciplinary model to improve the outcome in neonatal intensive care unit. J. Matern. Fetal Neonatal Med.24(Suppl. 2), S2–S3 (2011).
- Kern SE. Challenges in conducting clinical trials in children: approaches for improving performance. Exp. Rev. Clin. Pharmacol.2(6), 609–617 (2009).
- Mulder H, Pitchford NH, Marlow N. Inattentive behaviour is associated with poor working memory and slow processing speed in very pre-term children in middle childhood. Br. J. Educ. Psychol.81(Pt 1), 147–160 (2011).
- Farombi-Oghuvbu I, Matthews T, Mayne PD, Guerin H, Corcoran JD. N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus. Arch. Dis. Child. Fetal Neonatal Ed.93(4), F257–F260 (2008).
- Kuppens M, George I, Lewi L, Levtchenko E, Allegaert K. Creatinaemia at birth is equal to maternal creatinaemia at delivery: does this paradigm still hold? J. Matern. Fetal Neonatal Med. doi:10.3109/14767058.2011.602144 (2011) (Epub ahead of print).